Luminus Management LLC Ocugen, Inc. Transaction History

Luminus Management LLC

  • $170 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 15, 2024
SELL
$0.36 - $0.57 $394,586 - $624,761
-1,096,073 Reduced 40.26%
1,626,583 $927,000
Q3 2023

Nov 14, 2023
SELL
$0.4 - $0.62 $542,632 - $841,080
-1,356,582 Reduced 33.26%
2,722,656 $1.09 Million
Q2 2023

Aug 14, 2023
BUY
$0.45 - $0.88 $1.84 Million - $3.59 Million
4,079,238 New
4,079,238 $2.2 Million

Others Institutions Holding OCGN

# of Institutions
124
Shares Held
78.3M
Call Options Held
535K
Put Options Held
523K
View Full List

About Ocugen, Inc.

OCGN Quotes by TradingView
  • Ticker OCGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 216,566,000
  • Market Cap $167M
  • Description
  • Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmento...
More about OCGN
Track This Portfolio

Track Luminus Management LLC Portfolio

Follow Luminus Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Luminus Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Luminus Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email